Topical and systemic therapy for recurrent aphthous stomatitis

Area of Science:

• Immunology
• Dermatology
• Oral Medicine

Background:

• Recurrent aphthous ulcers (RAU), also known as recurrent aphthous stomatitis, have an incompletely understood etiology.
• Immune system dysfunction is implicated as a primary factor in the development of RAU.

Purpose of the Study:

• To review the various treatment modalities for recurrent aphthous ulcers.
• To evaluate the efficacy and side effect profiles of different therapeutic approaches for RAU.

Main Methods:

• Literature review of existing studies on recurrent aphthous ulcers.
• Analysis of treatment options, including systemic and topical medications, management of associated conditions, and palliative care.

Main Results:

• The most effective treatments for RAU involve immune-modulating agents such as systemic or topical corticosteroids and thalidomide.
• Topical treatments are generally preferred due to a lower incidence of systemic side effects.
• Challenges with topical treatments include achieving adequate contact time, potentially limiting effectiveness.

Conclusions:

• Immune system modulation is key to effective RAU treatment.
• Topical corticosteroids and thalidomide represent effective therapeutic strategies for recurrent aphthous ulcers.
• Adjunctive pain management may be necessary, utilizing pain medications or ulcer-coating agents.